IPRC is a privately owned
leading Clinical Research Organization (CRO), established by Prof. Naji Najib in 1997 to provide clinical & bioanalytical services for the pharmaceutical industry.
IPRC has successfully passed numerous inspections
by US-FDA, EMA, WHO and is accredited by the Turkish MOH. IPRC is approved by the
Jordan Food and Drug Administration as well by the Gulf Cooperation Council
(GCC).
IPRC has a fully-equipped clinic and bioanalytical facilities under the same roof. With 180 beds, the main facility is well-suited for mid-sized BE studies. The Bioanalytical laboratory has processed hundreds of thousands of samples and is complete with 28 state-of-the-art LCMSMS stations managed by Watson LIMSTM adhering to international standards.
In accordance with ICH-GCP regulations, IPRC provides quality research
services:
- Phase I bioavailability/bioequivalence/pharmacokinetics studies
- Clinical trials management, phase II-IV throughout the MENA region
- Bioanalysis
- Data management, PK, statistics & medical writing
With more than 100 professionals, IPRC has conducted more than 4500 bioequivalence, bioavailability and pharmacokinetics studies catered to US, EU,
AU, India
and MENA markets. IPRC’s reports are accepted by US-FDA, EMA and other Regulatory
Authorities worldwide.
